Mitochondrial quality control in acute liver injury and its therapeutic implications (Review)
Molecular Medicine Reports · 2026
DOI: 10.3892/mmr.2026.13984 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2026. Verfasst von Ziqiang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China. Hauptthemen laut MEDLINE: Mitochondria, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Acute liver injury (ALI) is a clinically important syndrome with limited mechanism‑based therapies. Notably, mitochondrial dysfunction is increasingly recognized as a central driver of hepatocellular damage and repair failure. The present narrative review aims to summarize the current evidence on mitochondrial quality control (MQC) in ALI, with an emphasis on mitophagy, mitochondrial biogenesis, mitochondrial dynamics, etiology‑specific regulation and therapeutic implications. For the present review, relevant experimental and translational studies addressing MQC‑related mechanisms and interventions in major forms of ALI, including drug‑induced liver injury, ischemia‑reperfusion injury and viral ALI, were reviewed and integrated. The findings indicated that MQC operates as an interconnected network rather than as isolated pathways. Mitophagy, mitochondrial dynamics and mitochondrial biogenesis are temporally coordinated to remove damaged mitochondria, remodel mitochondrial networks and restore bioenergetic capacity. However, MQC responses differ across ALI etiologies, and inappropriate or excessive activation may become maladaptive. In conclusion, understanding MQC as a dynamic and context‑dependent repair system may provide a conceptual basis for precision interventions in ALI. Future studies should clarify spatiotemporal MQC regulation, establish reliable biomarkers and validate MQC‑targeted therapies in clinically relevant settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
- Department of Endocrinology, Metabolism and Gastroenterology, The Third Affiliated Clinical Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130022, P.R. China.
- College of Basic Medical Sciences, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
- Department of Digestive Endoscopy, Songyuan Jilin Oilfield Hospital, Songyuan, Jilin 138099, P.R. China.
- College of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin 130117, P.R. China.
Zitieren
APA
Chen, Z., Wang, Y., Li, Y., Cong, G., Chu, Y., Bai, Y., Zhang, Y., & Zhou, L. (2026). Mitochondrial quality control in acute liver injury and its therapeutic implications (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2026.13984
Vancouver
Chen Z, Wang Y, Li Y, Cong G, Chu Y, Bai Y, et al. Mitochondrial quality control in acute liver injury and its therapeutic implications (Review). Molecular Medicine Reports. 2026. doi:10.3892/mmr.2026.13984
BibTeX
@article{Chen2026,
author = {Chen, Ziqiang and Wang, Yunhe and Li, Yijing and Cong, Gang and Chu, Yunhang and Bai, Yunhui and Zhang, Yishuo and Zhou, Liya},
title = {Mitochondrial quality control in acute liver injury and its therapeutic implications (Review)},
journal = {Molecular Medicine Reports},
year = {2026},
doi = {10.3892/mmr.2026.13984}
}
EUVIMED